Life sciences firm Quanterix Corporation is making waves in the precision health space with its innovative digital immunoassay platforms. The company's products are used in life sciences research and diagnostics in multiple regions around the world, including North America, Europe, the Middle East, Africa, and the Asia-Pacific. Quanterix's product line includes the HD-X instrument, an automated multiplex protein detection platform, and the SR-X instrument, which allows for the direct detection of nucleic acids. Additionally, the company provides assay kits, reagents, and contract research services, including sample testing, homebrew assay development, and custom development services. The company's core focus is primarily in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. Its clients are primarily associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies. Quanterix Corporation, headquartered in Billerica, Massachusetts, was originally founded as Digital Genomics, Inc. in 2007 before rebranding in August of that year.
Quanterix's ticker is QTRX
The company's shares trade on the NASDAQ stock exchange
They are based in Billerica, Massachusetts
There are 201-500 employees working at Quanterix
It is quanterix.com
Quanterix is in the Healthcare sector
Quanterix is in the Medical Appliances & Equipment industry
The following five companies are Quanterix's industry peers: